Clonal evolution and the risk of secondary myeloid neoplasia following chimeric antigen receptor T-cell therapy
Not available.
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-04-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/12049 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849315970116485120 |
|---|---|
| author | Francesca Sillito Alexandros Rampotas Kathleen Cheok Sabine Pomplun Robert Baker Teresa Marafioti Maeve O'Reilly Rajeev Gupta Amy A. Kirkwood Claire Roddie |
| author_facet | Francesca Sillito Alexandros Rampotas Kathleen Cheok Sabine Pomplun Robert Baker Teresa Marafioti Maeve O'Reilly Rajeev Gupta Amy A. Kirkwood Claire Roddie |
| author_sort | Francesca Sillito |
| collection | DOAJ |
| description |
Not available.
|
| format | Article |
| id | doaj-art-528b72ec6d764c718a68df9610319f48 |
| institution | Kabale University |
| issn | 0390-6078 1592-8721 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Ferrata Storti Foundation |
| record_format | Article |
| series | Haematologica |
| spelling | doaj-art-528b72ec6d764c718a68df9610319f482025-08-20T03:51:59ZengFerrata Storti FoundationHaematologica0390-60781592-87212025-04-01999110.3324/haematol.2025.287341Clonal evolution and the risk of secondary myeloid neoplasia following chimeric antigen receptor T-cell therapyFrancesca Sillito0Alexandros Rampotas1Kathleen Cheok2Sabine Pomplun3Robert Baker4Teresa Marafioti5Maeve O'Reilly6Rajeev Gupta7Amy A. Kirkwood8Claire Roddie9University College London Hospitals, LondonUniversity College London Hospitals, London, UK; University College London (UCL) Cancer Institute, UCL, LondonUniversity College London Hospitals, LondonUniversity College London Hospitals, LondonMolecular Haematology, Health Services Laboratories, London WC1H 9AXUniversity College London Hospitals, London, UK; University College London (UCL) Cancer Institute, UCL, LondonUniversity College London Hospitals, LondonUniversity College London Hospitals, London, UK; University College London (UCL) Cancer Institute, UCL, London, UK; Molecular Haematology, Health Services Laboratories, London WC1H 9AXUniversity College London (UCL) Cancer Institute, UCL, London, UK; CRUK and UCL Cancer Trials Centre, UCL Cancer Institute, UCLUniversity College London Hospitals, London, UK; University College London (UCL) Cancer Institute, UCL, London Not available. https://haematologica.org/article/view/12049 |
| spellingShingle | Francesca Sillito Alexandros Rampotas Kathleen Cheok Sabine Pomplun Robert Baker Teresa Marafioti Maeve O'Reilly Rajeev Gupta Amy A. Kirkwood Claire Roddie Clonal evolution and the risk of secondary myeloid neoplasia following chimeric antigen receptor T-cell therapy Haematologica |
| title | Clonal evolution and the risk of secondary myeloid neoplasia following chimeric antigen receptor T-cell therapy |
| title_full | Clonal evolution and the risk of secondary myeloid neoplasia following chimeric antigen receptor T-cell therapy |
| title_fullStr | Clonal evolution and the risk of secondary myeloid neoplasia following chimeric antigen receptor T-cell therapy |
| title_full_unstemmed | Clonal evolution and the risk of secondary myeloid neoplasia following chimeric antigen receptor T-cell therapy |
| title_short | Clonal evolution and the risk of secondary myeloid neoplasia following chimeric antigen receptor T-cell therapy |
| title_sort | clonal evolution and the risk of secondary myeloid neoplasia following chimeric antigen receptor t cell therapy |
| url | https://haematologica.org/article/view/12049 |
| work_keys_str_mv | AT francescasillito clonalevolutionandtheriskofsecondarymyeloidneoplasiafollowingchimericantigenreceptortcelltherapy AT alexandrosrampotas clonalevolutionandtheriskofsecondarymyeloidneoplasiafollowingchimericantigenreceptortcelltherapy AT kathleencheok clonalevolutionandtheriskofsecondarymyeloidneoplasiafollowingchimericantigenreceptortcelltherapy AT sabinepomplun clonalevolutionandtheriskofsecondarymyeloidneoplasiafollowingchimericantigenreceptortcelltherapy AT robertbaker clonalevolutionandtheriskofsecondarymyeloidneoplasiafollowingchimericantigenreceptortcelltherapy AT teresamarafioti clonalevolutionandtheriskofsecondarymyeloidneoplasiafollowingchimericantigenreceptortcelltherapy AT maeveoreilly clonalevolutionandtheriskofsecondarymyeloidneoplasiafollowingchimericantigenreceptortcelltherapy AT rajeevgupta clonalevolutionandtheriskofsecondarymyeloidneoplasiafollowingchimericantigenreceptortcelltherapy AT amyakirkwood clonalevolutionandtheriskofsecondarymyeloidneoplasiafollowingchimericantigenreceptortcelltherapy AT claireroddie clonalevolutionandtheriskofsecondarymyeloidneoplasiafollowingchimericantigenreceptortcelltherapy |